Drug Solutions Podcast: Realizing AI’s Potential
This episode is a compilation of comments taken from a series of interviews where experts are discussing how AI might impact the global bio/pharma industry in the future.
In this episode of the Drug Solutions podcast, Felicity Thomas, Associate Editorial Director, chats with a host of experts about artificial intelligence (AI) and the potential impact AI and machine learning may have on the global bio/pharma industry in the near future.
About the Speakers
Dr. Ben Sidders is chief scientific officer for Biorelate—an AI platform company that provides data solutions to pharma companies
Adam Sherlock is CEO of Qinecsa Solutions, which is a UK headquartered but international pharmacovigilance technology and services solution provider.
Kate Coleman is vice president of Regulatory Quality and Compliance, Arriello—a life sciences consultancy.
Alexander Seyf is CEO of Autolomous, which uses smart technology to help ATMP manufacturers.
Michelle Bridenbaker is COO of Unbiased Science and vice-president of the Medical Information Leaders in Europe (MILE).
About the Drug Solutions Podcast
Pharmaceutical Technology presents the Drug Solutions podcast, where the editors will chat with industry experts from across the pharmaceutical and biopharmaceutical supply chain. Join us as experts share insights into your biggest questions—from the technologies, to strategies, to regulations related to the development and manufacture of drug products.
Listen to this podcast on SoundCloud, Spotify, Google Podcasts, or Apple Podcasts.
